Referral Management Market worth $2686.3 Million by 2019

The “Referral Management Market by Type (Self-referral, Professional-referral, & Third party-referral), Component (Software, & Services), Delivery Mode (On-Premise, Web, & Cloud), End-user (Provider, Payer) - Trend & Global Forecast to 2019”, analyzes and studies the major market drivers, restraints, and opportunities, in North America, Europe, Asia, and Rest of the World (RoW).

                  

Browse 76 market data tables and 49 figures spread through 154 pages and in-depth TOC on “Referral Management Market by Type (Self-referral, Professional-referral, & Third party-referral), Component (Software, & Services), Delivery Mode (On-Premise, Web, & Cloud), End-user (Provider, Payer) - Trend & Global Forecast to 2019"
https://www.marketsandmarkets.com/Market-Reports/referral-management-market-196292082.html
Early buyers will receive 10% customization on reports.

This report studies the global referral management market over the forecast period of 2014 to 2019. This market was valued at $988 million in 2014 and is poised to grow at a CAGR of 22.1% from 2014 to 2019, to reach $2,686.3 million by 2019.

The referral management market is segmented on the basis of type, component, delivery mode, end user, and region. The market, by type, is categorized into self-referrals, professional referrals, and third-party referrals. By component, the market is divided into software and services. Based on delivery mode, the market is categorized into web-based, on-premise, and cloud-based. The market by end user is categorized into providers, payers, patients, and others. Based on region, the market is divided into North America, Europe, Asia, and the Rest of the World (Pacific, the Middle East & Africa, and Latin America).

The major factors driving the growth of the referral management solutions market are increasing government initiatives to incorporate IT solutions in healthcare globally, rise in aging population and incidence of chronic disease, the benefits of referral management solutions, and the shortage of nursing staff and doctors. However, despite the benefits of referral management solutions, certain barriers such as the failure to reduce outpatient attendance, lack of skilled healthcare IT professionals, and security concerns are restraining the growth of this market.

In 2014, the North American market commanded the largest share of the global referral management market, followed by Europe and Asia. Asia is the fastest-growing region in this market. Although the Asian segment is relatively new in the referral management market, the increasing HCIT adoption, proficiency of IT skills, and the growing healthcare expenditure in countries like India will drive the growth of this market in Asia.

The major players in the global referral management market include Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), McKesson Corporation (U.S.), ReferralMD (U.S.), Harris Corporation (U.S.), The Advisory Board Company (U.S.), ehealth Technologies (U.S), Eceptionist, Inc. (U.S.), Clarity Health (U.S.), and Kyruus, Inc. (U.S.)

Drug Discovery Informatics Market worth 2.84 Billion USD by 2022

The report "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022", The global drug discovery informatics market is expected to reach USD 2.84 Billion from USD 1.67 Billion at a CAGR of 11.2%. Rising R&D expenditure and increasing focus on drug discovery are the major factors driving the adoption of discovery informatics solutions.

Browse 63 market data Tables and 24 Figures spread through 115 Pages and in-depth TOC on "Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, Contract Research Organization) - Global Forecast to 2022"
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-informatics-market-64537381.html
Early buyers will receive 10% customization on reports.

Based on function, the sequencing and target data analysis segment is accounted for the largest share of the market in 2017

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

Based on solution, the software segment is accounted for the largest share of the market in 2017

The solution segment of the drug discovery informatics market is divided into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The dominant share of this market is attributed to the fact that drug discovery informatics software solutions enable the fast and efficient management of data generated throughout the drug discovery process.

North America is expected to dominate the market in 2017

The North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

The global vaccine adjuvants market consists of human and veterinary adjuvants that are used to improve the efficacy of vaccines. This market is driven by several factors such as increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on prevention of diseases. The high growth potential in emerging markets has opened an array of opportunities for the market. However, the high cost of adjuvant-based research and proven safety of adjuvants are hampering the growth of the global market.

https://www.marketsandmarkets.com/Market-Reports/vaccine-adjuvants-market-152603894.html

The vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016 at a CAGR of 10.5%. This market is segmented based on product type, route of administration, disease type, applications, and application category.

On the basis of product type, the market is segmented into pathogen components, adjuvant emulsions, particulate adjuvants, combination adjuvants, and other adjuvants. The particulate adjuvants segment is expected to account for the largest share of the global vaccine adjuvants market in 2016. High prevalence of infectious diseases and increasing funding for adjuvant research will drive the growth of this market segment.

Based on route of administration, the vaccine adjuvants market includes oral route, subcutaneous route, intranasal route, intramuscular route, intradermal route, and other routes. The intramuscular segment is expected to account for the largest share of the global market in 2016. Rising geriatric population and vaccines for improved immunization are the key factors propelling the growth of this market.

Based on disease type, the vaccine adjuvants market comprises of infectious diseases, cancer, and other diseases. The infectious diseases segment is expected to account for the largest share of the global market in 2016. High prevalence of infectious diseases and cancer is expected to drive market growth in the coming years.

Based on applications, the vaccine adjuvants market is segmented into research applications and commercial applications. The research applications segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to factors such as ongoing research on new adjuvants, increasing initiatives by government bodies and companies, usage of many vaccine adjuvants commercially, increasing incidences of zoonotic diseases, and increase in the number of conferences and summits.

Download PDF brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=152603894

Based on application categories, the vaccine adjuvants market is segmented into human and veterinary adjuvants. The human vaccine adjuvants segment is expected to account for the largest share of the global market in 2016 and is expected to have a higher growth rate in the application category segment. The large share of this segment can be attributed to the increasing initiatives by companies, vaccine adjuvants discovery and development, and increase in the number of conferences and summits.

Based on geography, the global vaccine adjuvants market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). However, Asia is expected to witness the highest CAGR, with the growth in this market centered at China and India. Rising prevalence of infectious diseases, increasing government investments for vaccine research and development, rising number of conferences and symposiums, and high growth in the Indian biotechnology sector are the major factors driving the market in the Asian region.

The major players in the vaccine adjuvants market are Brenntag Biosector (Denmark), CSL Limited (Australia), SEPPIC (France), Agenus, Inc. (U.S.), Novavax, Inc. (U.S.), SPI Pharma, Inc. (U.S.), Invivogen (U.S.), Avanti Polar Lipids, Inc. (U.S.), MVP Laboratories, Inc. (U.S.), and OZ Biosciences (France).

Protein Engineering Market worth $1,463.0 Million by 2020

The protein engineering market is expected to grow at a double–digit CAGR of 15.7% to reach $1,463.0 million by 2020 from $705.5 million in 2015. Major factors fueling market growth are the increase in adoption of protein drugs over non-protein drugs, high prevalence rate of lifestyle diseases, growth in funding for protein engineering, and reduction in overall timeline and cost for drug discovery. However, expensive and high maintenance tools and instruments used in protein engineering and dearth of trained personnel are restricting the growth of the market.

https://www.marketsandmarkets.com/Market-Reports/protein-antibody-engineering-market-898.html

This market is broadly segmented into instrument, reagent and services and software, by product. On the basis of technology the market is segmented into rational protein design, and irrational protein design. Rational protein design emerged as highly adopted technology in protein engineering market in 2014.

Based on protein type, the market is categorized into monoclonal antibodies, insulin, erythropoietin, interferon, colony stimulating factor, growth hormones, coagulation factor, vaccines and others (interleukins, follicle stimulating hormones, enzyme replacement). Monoclonal antibodies is the largest as well as fastest growing segment of the protein engineering protein type market.

Based on end user, the protein engineering market is broadly classified into academic research institutes, pharmaceutical and biotechnology companies and contract research organizations. Pharmaceutical and biotechnology companies is the largest and fastest-growing end user segment. The high growth rate of this market can be attributed to technological advancements in protein engineering and the increase in R&D budgets in the pharmaceutical sector.

Geographically, this market is dominated by North America, followed by Europe. Asia is expected to be the fastest growing region during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=898

Key players operating in this market are AB-Sciex (U.S.),  Agilent Technologies (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Bruker Corp. (U.S.), , GE Healthcare (U.K.), Perkin Elmer (U.S.), Sigma-Aldrich Corp. (U.S.), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Atherectomy Devices Market by Type, Application & End User - 2022

The global atherectomy devices market is projected to reach USD 1.45 Billion by 2022 from USD 1.08 Billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers.

https://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html

This report broadly segments the atherectomy devices market into product, application, end user, and region. On the basis of product, the market is categorized into directional, photo-ablative (laser), orbital, rotational atherectomy systems, and support devices. In 2017, the directional atherectomy devices segment is expected to account for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to the significant availability of credible clinical data to validate their clinical efficacy, rising availability of reimbursements for vascular treatment procedures across developed countries, high preference for minimally invasive procedures among medical professionals, clinical benefits offered, and ongoing technology advancements in the field of directional atherectomy.

Based on application, the atherectomy devices market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the largest share of the market and is expected to be the fastest growing segment during the forecast period. The large share of this segment is attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment and rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Based on end user, the atherectomy devices market is segmented into three categories, namely, hospitals and surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment accounted for the largest share of the market due to the increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment and growing availability of healthcare reimbursements across major countries.

This report covers the atherectomy devices market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America is expected to command the largest share of the market in 2017. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.

Factors such as stringent regulatory framework, significant adoption of alternative therapies, and dearth of well-trained surgeons to conduct atherectomy procedures are expected to restrain the growth of the atherectomy devices market during the forecast period.

The major players in the atherectomy devices market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), Cardiovascular Systems (US), Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

Global Gastrointestinal Stents Market to Reach USD 452.6 Million by 2022

The global gastrointestinal stents market is projected to reach USD 452.6 million by 2022 from USD 353.4 million in 2017, at a CAGR of 5.1% during the forecast period. The increasing preference for minimally invasive surgeries and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The base year considered for the study is 2016, while, the forecast period is 2017 to 2022.

“Gastrointestinal / GI Stent Market By Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast To 2022”

https://www.marketsandmarkets.com/Market-Reports/gastrointestinal-gi-stent-market-167758126.html

Browse 177 market data Tables and 32 Figures spread through 184 Pages and in-depth TOC on "Gastrointestinal Stents Market–Global Forecast to 2022.”

Early buyers will receive a 10% customization on reports

“By product, the biliary stents segment accounted for the largest share of the gastrointestinal stents market in 2016.”

On the basis of product, the biliary stents segment accounted for the largest share of the global gastrointestinal stents market. This can be attributed to the high prevalence of pancreatic cancer and biliary diseases as well as growth in the number of surgical procedures for the treatment of these diseases.

“By disease type, the biliary diseases segment held the largest market share of the gastrointestinal stents market in 2016.”

On the basis of disease type, the biliary diseases segment accounted for the largest share of the gastrointestinal stents market. The large share of this segment is attributed to the high prevalence of gastrointestinal diseases in the elderly population.

“The ambulatory surgery centers segment is expected to witness the highest growth rate in the gastrointestinal stents market, by end user, during the forecast period.”

Based on end user, the ambulatory surgery centers segment is expected to register the highest CAGR during the forecast period. Scheduling delays for operation, slow operating room turnover times, and the need for increasing the number of operating rooms in hospitals are the major factors supporting the growth of ASCs.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=167758126

 “North America dominated the gastrointestinal stents market in 2016.”

North America accounted for the largest share of the gastrointestinal stents market in 2016, followed by Europe and Asia Pacific. The developed healthcare system, rising geriatric population, and high prevalence of gastrointestinal cancers are the major factors responsible for the large share of North America in the gastrointestinal stents market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=167758126

The prominent players in the global gastrointestinal stents market are Boston Scientific (US), Cook Group (US), C.R. Bard (US), ELLA-CS (Czech Republic), Becton, Dickinson and Company (US), Merit Medical Systems (US), CONMED (US), Cantel Medical (US), Olympus (Japan), Taewoong Medical (South Korea), Micro-Tech (Nanjing) (China), Endo-Flex (Germany), and M.I. Tech (South Korea).

Clinical Trial Supplies Market by Products & Services (Logistics & Distribution, Manufacturing, Packaging and Labeling), Phases (Phase I, Phase II, Phase III) & Therapeutic Areas (CNS & Mental Disorders, Cardiovascular, Oncology) - Global Forecast to 2020

The global clinical trial supplies market is expected to reach USD 1,274.3 Million by 2020 from USD 904.3 Million in 2015, at a CAGR of 7.1%. The global market is broadly classified into manufacturing services, packaging and labeling services, and logistics and distribution services. The logistics and distribution segment is expected to account for the largest share of the global clinical trial supplies products market in 2015.

https://www.marketsandmarkets.com/Market-Reports/clinical-trial-supplies-market-172240059.html

On the basis of phases, the clinical trial supplies market is segmented into phase I, phase II, and phase III. The phase III segment is expected to account for the largest share of the global market in 2015. On the basis of therapeutic areas, the clinical trial supplies market has been segmented into oncology, cardiovascular and metabolic disorders, respiratory diseases, CNS and mental disorders, dermatology disorders, blood disorders, infectious diseases, and others. The oncology segment is expected to account for the largest share of the global market in 2015.

Geographically, the clinical trial supplies market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Growth in the North American segment is primarily driven by rising prevalence of patients suffering from chronic diseases, growing number of clinical trials, and the increasing number of life science research activities in the U.S. and Canada.

The major players in the market are Alamc Group LTD (U.K.), Catalent Pharma Solutions, Inc. (U.S.), KLIFO A/S (Denmark), Movianto (Germany), PCI Services (U.S.), Patheon, Inc. (U.S.), PAREXEL International Corporation (U.S.), Sharp Packaging Services (U.S.), Biocair (U.K.), and Thermo Fisher Scientific, Inc. (U.S.).

Target Audience for this Report:

• Clinical trial supplies CROs
• Healthcare Institutions (Hospitals and Clinics)
• Clinical Trial Supplies Service Providers
• Research Institutions
• Research and Consulting Firms
• Environment, Health, and Safety Organizations

Value Addition for the Buyer:

This report aims to provide insights into the global clinical trial supplies market. It provides valuable information on the products and services, phases, and therapeutic areas in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product/service offerings and understand the strategies undertaken by them to be competitive in this market.

https://www.marketsandmarkets.com/requestsample.asp?id=172240059

The above-mentioned information would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

Customization Options:

• Company Information: Detailed company profiles of five or more market players
• Opportunities Assessment: A detailed report underlining the various growth opportunities presented in the market

https://www.marketsandmarkets.com/pdfdownload.asp?id=172240059

Scope of the Report:

This report categorizes the clinical trial supplies market into the following segments:

By Products and Services

• Manufacturing
• Packaging and Labeling
• Logistics and Distribution

Optical Imaging Market by Applications, Technique, Product & Therapeutic Area - 2020

The report "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020", The Global Optical Imaging Market Is Expected to reach USD 1,749.2 Million by 2020. The market was valued at USD 989.0 Million in 2015 and is expected to grow at a CAGR of 12.1% from 2015 to 2020.

Browse 161 market data Tables and 43 Figures spread through 200 Pages and in-depth TOC on "Optical Imaging Market by Technique (OCT, NIRS, HSI, PAT) by Product (Imaging System, Camera, Lens, Software) by Therapeutic Area (Ophthalmology, Oncology, Neurology, Dermatology), by Application (Pathological, Intra-operative) - Global Forecast to 2020"
https://www.marketsandmarkets.com/Market-Reports/optical-imaging-technologies-market-894.html
Early buyers will receive 10% customization on reports.

Owing to the technological advancements and increasing application areas of optical imaging techniques in pharmaceutical and biotechnological industries and medical diagnostics & therapeutics, the optical imaging market recorded a healthy growth rate during last decade. Optical imaging is extensively used for several applications including preclinical research, disease diagnosis, imaging of various cellular and molecular processes in vivo including protein interactions, protein degradation, and protease activity. Thus, increasing research activities in the biopharmaceutical industry and rising applications of optical imaging modalities for therapeutic and diagnostic purposes is expected to have a positive impact on the growth of this market. Moreover, uptake of optical imaging techniques due to growing demand for non-invasive & non-ionizing imaging modalities with ageing population and integration of optical imaging techniques with other imaging modalities is expected to drive the demand for optical imaging products in the coming years. However, high installation cost, complex regulatory requirements, and lack of skilled operators is likely to hinder the growth of the market to a certain extent.

In this report, the global optical imaging market is segmented by techniques, products, applications, end users, geographic regions, and countries. It also discusses the key market drivers, restraints, opportunities, trends, and challenges of this market and its sub-markets.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=894

In 2013, North America accounted for the largest share of the global optical imaging market, followed by Europe and Asia-Pacific. Greater uptake of optical imaging products and the presence of large number of optical imaging products manufacturers in the North American and European region has led to their large market share in the optical imaging market. However, the Asia-Pacific region represents the substantial growth opportunity for the optical imaging market during the forecast period of 2015 to 2020. The growth in this region is primarily driven by increased focus on healthcare growth in geriatric population, rising per capita income, increasing investments in the APAC healthcare industry by key market players, rising demand for cutting-edge technologies, and low labor costs.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=894

The prominent players in the optical imaging market include Carl Zeiss Meditec AG (Germany), Bioptigen, Inc. (U.S.), Topcon Medical Systems, Inc. (U.S.), St. Jude Medical, Inc. (U.S.), Canon, Inc. (U.S.), and PerkinElmer, Inc. (U.S.),

Top 10 Medical Device Technologies Market by type & Technology - 2020

The growth in the top 10 medical devices industry is mainly driven by the rising prevalence of chronic lifestyle diseases like cardiovascular, diabetes, hypertension, cancer, and respiratory problems. Similarly, the rising acceptance of newer technologies by physicians & hospitals and growing geriatric population are also driving the overall growth of the top 10 medical devices market. However, factors such as uncertainty in reimbursement and the imposition of the medical device excise tax in the U.S. are restraining the growth of this market.

https://www.marketsandmarkets.com/Market-Reports/top-10-medical-device-technologies-96.html

In this report, the top 10 medical device technologies market is segmented on the basis of type and region. On the basis of type, the market is segmented into IVD devices, cardiology devices, diagnostic imaging devices, orthopaedic devices, ophthalmology devices, endoscopy devices, diabetes care devices, wound management devices, kidney/dialysis devices, and anesthesia & respiratory care devices. In 2014, the IVD devices segment accounted for the largest share­—17.1%—of the global top 10 medical device technologies market, and is poised to grow at a CAGR of 5.8% during the forecast period. The large share of this segment is mainly attributed to the prevalence of diabetes, cardiovascular diseases, and cancer. Similarly, the rising incidence of respiratory infections, hospital-acquired infections, other infectious diseases, and sexually transmitted diseases are also driving the growth of this market.

However, anesthesia and respiratory care devices is the fastest-growing segment during the forecast period, growing at a CAGR of 8.7%. This segment accounted for a share of 6.7% of the global top 10 medical device technologies market in 2014.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=96

Geographically, North America accounted for the largest share of ~39.7% of the top 10 medical device technologies market in 2014, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The large share of North America in the global top 10 medical device technologies market is mainly attributed to greater accessibility to advanced technologies, rising prevalence of chronic lifestyle diseases, rising geriatric population, increasing number of surgical procedures, increasing acceptance of personalized medicine, and established distribution channels in this region as compared to Europe and APAC. However, the Asia-Pacific region is expected to be the fastest-growing top 10 medical device technologies market during the forecast period. Growing population in countries like China and India, rapid growth in geriatric population, improving healthcare infrastructure, growing per capita income, and rising focus of key market players on this region are contributing to the growth of the top 10 medical device technologies market in the APAC region during the forecast period.

Request Sample: https://www.marketsandmarkets.com/requestsample.asp?id=96

The global top 10 medical device technologies market is fragmented in nature. Prominent players in this market include Johnson & Johnson (U.S.), GE Healthcare (U.K.), Siemens Healthcare (Germany), Medtronic (U.S.), Philips Healthcare (Netherlands), Roche Diagnostics (Switzerland), Abbott Laboratories Inc. (U.S.), Smith & Nephew plc (U.K.), Stryker Corporation (U.S.), and Boston Scientific Corporation (U.S.). The leading players in this market have built a strong market position over the years by focusing on new product launches; agreements, collaborations, and partnerships; and expanding their geographic presence in emerging markets in order to widen their revenue streams. These still remain the actively adopted strategies by leading players in this market, in order to achieve sustainable revenue growth in the competitive top 10 medical devices market.

Medical Automation Market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

Emerging Asia-Pacific countries, including India and China, offer high growth potential for companies engaged in the development and marketing of automated solutions for the healthcare industry. Growing geriatric population; increasing cases of cardiovascular disease (CVD), diabetes, cancer, and orthopedic diseases; rising clinical research; and growing government expenditure on healthcare and life science research are the key factors propelling the growth of the medical automation market in the emerging countries.

On the basis of application, the medical automation market is divided into four segments, namely, diagnostic and monitoring automation (automated image analysis, automated imaging, and point-of-care testing), therapeutic automation (non-surgical automation and surgical automation), laboratory and pharmacy automation (laboratory automation and pharmacy automation), and medical logistics and training (logistic automation and trainers). The medical logistics and training segment is expected to grow at the highest rate in the next five years, owing to high adoption of these automated systems (pneumatic tubes, AGV, RTLS, and RFID) by big hospitals and diagnostic centers.

The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020.

The therapeutic automation market segment holds the largest share in the global medical automation market. This segment is further categorized on the basis of product into non-surgical automation (defibrillators and automated medication systems) and surgical automation (surgical robots, intraoperative imaging, surgical navigation, intelligent operating rooms, and surgical simulators). In 2015, the non-surgical automation segment held a larger share of 72.9% of the global therapeutic automation market. The increasing incidences of various chronic diseases and technological advancements in defibrillators and medication systems are the key factors contributing to the growth of this market segment.

The global medical automation market is divided into four segments on the basis of end users– hospitals and diagnostic centers, pharmacies, research laboratories and institutes, and home/ambulatory care settings and other end users.

The global medical automation market is estimated to grow at a CAGR of 9.5% from 2015 to 2020. A number of factors such as continuous advancements in various medical automation technologies; increasing government financial support for medical automation; and growing adoption of automation in laboratory, pharmacy, and medical logistics operations are propelling the growth of the global medical automation market. However, high cost of automation and stringency of regulatory procedures leading to delayed product launches are the key factors restraining the growth of this market.

On the basis of geography, medical automation  market is classified into four regions, namely, North America (U.S. and Canada), Europe, Asia-Pacific, and the Rest of the World. In 2015, the global medical automation market is estimated to be dominated by North America. Large number of ongoing clinical trials in the U.S., high adoption rate of technologically advanced medical devices in this region, and developed healthcare reimbursement structure are contributing to the large share of the North American medical automation market. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. Factors such as growing government expenditure on healthcare research, rising number of clinical research activities owing to increasing R&D outsourcing to developing Asian countries, increasing old age population and associated diseases, availability of a large patient pool, and developing healthcare infrastructure are propelling the growth of the Asia-Pacific medical automation market.

http://www.marketsandmarkets.com/Market-Reports/medical-automation-technologies-market-848.html

New product launches, product approvals, and product enhancements is the primary growth strategy adopted by major players to enhance their positions in the global medical automation market. Moreover, strategies such as partnerships, agreements, and collaborations; geographic expansions; and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the market.

Koninklijke Philips N.V. (Netherlands), Siemens AG (Germany), General Electric Company (U.S.), Intuitive Surgical, Inc. (U.S.), Medtronic plc (U.S.), Tecan Group Ltd. (Switzerland), Stryker Corporation (U.S.), Accuray Incorporated (U.S.), Danaher Corporation (U.S.), and Swisslog Holding AG (Switzerland) are some of the key players operating in the global medical automation market.

Download PDF Brochure:  http://www.marketsandmarkets.com/pdfdownload.asp?id=848

Scope of the Report

This research report categorizes the global medical automation market into the following segments:

Global Diagnostics and Monitoring Automation Market

• Automated Imaging
  • Automated Fluoroscopy
  • Automated Radiography
  • Automated Microscopy
  • Capsule Endoscopy
• Point-of-care Testing (POCT)
• Automated Image Analysis

Global Therapeutic Automation Market

• Non-surgical Automation Market
  • Defibrillators
    • Implantable Cardioverter Defibrillators
    • Automated External (Portable) Defibrillators
    • Wearable Defibrillators
    • Automated Medication Delivery Systems
      • Implantable Drug Pumps
      • Wearable Drug Pumps
• Surgical Automation Market
  • Surgical Robots
    • da Vinci
    • CyberKnife
    • RIO
    • Renaissance
  • Intelligent Operating Rooms
  • Intraoperative Imaging
    • Intraoperative Ultrasound
    • Intraoperative CT
    • Intraoperative MRI
  • Surgical Navigation Systems
  • Surgical Simulators

Global Pharmacy and Laboratory Automation Market

• Laboratory Automation Market
  • Automated Liquid Handling
  • Microplate Readers
  • Software & Informatics
  • Standalone Robots
  • Automated Storage & Retrieval Systems (ASRS)
• Pharmacy Automation Market
  • Automated Medication Dispensing Systems
  • Automated Packaging and Labeling Systems
  • Automated Medication Compounding Systems

Global Medical Logistics & Training Automation Market

• Logistics Automation
  • Hospital Asset/Patient/Staff Tracking Systems Market
    • Radiofrequency Identification
    • Real-time Location Systems (RTLS)
  • Automated Hospital Pickup & Delivery
    • Pneumatic Tube Systems (PTS)
    • Automated Guided Vehicles (AGV)
• Trainers

Global Medical Automation Market, by End User

• Hospitals & Diagnostic Centers
• Research Laboratories & Institutes
• Pharmacies
• Home/Ambulatory Care Settings & Others

Global Medical Automation Market, by Region

• North America
  • U.S.
  • Canada
• Europe
• Asia-Pacific
• Rest of the World

Foot and Ankle Devices Market by Product & Cause of Injury - 2020

Foot and ankle devices are used in various procedures like total ankle replacement, ankle fusions, fracture reduction, bunion removal, and diabetic foot amputation, among others. The products used in treating foot and ankle disorders include screws, wires and pins, plates, fusion nails, fixators, joint implants, soft tissue orthopedic implants, and bracing systems, among others. The foot & ankle joint implants market comprises reconstructive devices or implants used to replace failed joints, while soft tissue orthopedic devices help repair injuries of internal ligaments and tendons.

https://www.marketsandmarkets.com/Market-Reports/foot-ankle-devices-market-845.html

The global foot and ankle devices market is segmented on the basis of product, cause of injury, and region. By product, the market is categorized into orthopedic implants and devices, prostheses, and bracing and supporting devices. In 2015, the orthopedic implants and devices segment is estimated to account for the largest share of the foot and ankle market. This segment is expected to grow at the fastest rate during the forecast period.

On the basis of cause of inury, the market is divided into trauma, diabetes, neurological disorders, and others (osteoporosis, rheumatoid arthritis, osteoarthritis, hammertoe, and bunions). In 2015, the others segment is expected to account for the largest share of the market. However, the trauma segment is expected to grow at a faster rate during the forecast period.

Growth in the number of sports injuries, an expected global rise in prevalence of diabetes, the rising prevalence of arthritis in Australia and the U.S., the regular entry of new products in the market, and rising geriatric population (resulting in growing incidence of bone) injuries are the major factors driving this market. On the other hand, the high cost of some foot and ankle devices and the excise tax on medical devices in the U.S. and are expected to restrain the growth of the market. The lack of trained professionals is a major challenge for the global market. However, the introduction of biologics to treat foot and ankle disorders and expansion & penetration opportunities in BRIC and South Africa are lucrative opportunities in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=845

On the basis of regions, this market is categorized into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

The foot and ankle devices market is expected to reach USD 5.41 Billion in 2020 from USD 3.82 Billion in 2015 at a CAGR of 7.2%. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period.

Some major players in the global market include Stryker Corporation (U.S.), Arthrex, Inc. (U.S.), Zimmer Biomet Holdings, Inc. (U.S.), Smith & Nephew plc (U.K.), Wright Medical Technology, Inc. (U.S.), Integra LifeSciences Holdings Corporation (U.S.), Tornier N.V. (Netherlands), Össur (Iceland), Acumed, LLC (U.S.), and Extremity Medical, LLC (U.S.).

Professional Dental Care Market worth 961.0 Million USD by 2021

The report "Professional dental care market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021", analyzes and studies the major market drivers, restraints, challenges, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 172 market data tables and 26 figures spread through 178 pages and in-depth TOC on “Professional Dental Care Market by Type (Toothbrush (Electric, Battery-powered), Toothpaste, Mouthwash, Denture Products, Dental Accessories (Whitening Products, Breath Freshener, Dental Floss, Dental Water Jet)) - Global Forecast to 2021"

https://www.marketsandmarkets.com/PressReleases/professional-dental-care.asp

Early buyers will receive 10% customization on reports.

The professional dental care market witnessed moderate growth during the last decade and is expected to grow at a CAGR of 4.5% between 2016 and 2021 to reach USD 961.0 Million by 2021. The growth in this market is majorly attributed to factors such as increasing small/private dental clinics, rising incidences of dental caries, increasing disposable incomes in emerging countries, growing awareness about dental hygiene, and economic gain for dental practitioners.

The global professional dental care market is segmented based on product type and geography. In recent years, the dental industry is gaining more importance due to increased demand of having specialized products, treatments and procedures to treat dental diseases. In 2015, toothpastes segment accounted for the largest share of global professional dental care market. The toothbrushes segment is expected to witness the fastest growth over the next five years. The high growth of this segment can be attributed to higher utilization of the manual toothbrushes by end-users and recent technological advancements in the electric toothbrushes.

Europe is the largest regional segment for professional dental care market owing to the well-established dental market. The largest share of this regional segment is driven by the increase in the aging population, rising demand for the advance oral care products, increase in governmental expenditure on oral healthcare across Europe, and rising awareness about dental hygiene. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising geriatric population, rising awareness about dental hygiene, and increase medical tourism in countries such as India and China. The market players, namely, Colgate-Palmolive Company (U.S.), The Procter & Gamble Company (U.S.), GlaxoSmithKline plc (U.K.), and Unilever plc (U.K.) held the major share of the professional dental care market and will continue to dominate the market between 2016 and 2021.

Some of the other players operating in this market are Johnson and Johnson (U.S.), Dr. Fresh, LLC (U.S.), Young Innovation Inc. (U.S.), Ultradent Products, Inc. (U.S.), GC Corporation (Japan), Henkel AG & Company, KGaA (Germany), 3M Company (U.S.), Koninklijke Philips N.V. (Netherlands), and Sunstar (Japan).

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Atherectomy Devices Market worth 1.45 Billion USD by 2022

The global atherectomy devices market accounted is projected to reach USD 1.45 Billion by 2022 from USD 1.02 Billion in 2016, at a CAGR of 6.1% during the forecast period.

For Report, please click here

Years considered for the study are as follows:

• Base Year: 2016
• Forecast Period: 2017–2022 

Objectives of the study are:

• To define, describe, segment and forecast the global atherectomy devices market on the basis of product, application, end user, and region
• To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
• To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
• To analyze the growth opportunities in the market for key stakeholders and provide details of the competitive landscape for leading market players
• To forecast the size of market segments with respect to four main regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
• To profile the key market players active in the global atherectomy devices industry and comprehensively analyze their market shares and core competencies
• To track and analyze competitive developments such as new product developments & commercialization, acquisitions, market expansions, and agreements & collaborations in the atherectomy devices market

Download PDF Brochure

This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the atherectomy devices market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.

To know about the assumptions considered for the study, download the pdf brochure

In 2016, Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US) held the leading position in the global atherectomy devices market. In the past three years, these companies adopted product launches, strategic acquisitions, mergers, agreements, collaborations, and expansions as their key business strategies to ensure market dominance. Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US) are some of the other major players in this market.

Request Sample

Stakeholders

• Original equipment manufacturers (OEMs)
• Product sales and distribution companies
• Healthcare service providers (hospitals and surgical centers)
• Non-government organizations
• Government regulatory authorities
• Research laboratories and academic institutes
• Clinical research organizations (CROs)
• Research and development companies
• Market research and consulting firms

Scope of the Report

This report categorizes the global atherectomy devices market into the following segments and sub segments:

Global Atherectomy Devices Market, by Product

• Directional Atherectomy Devices
• Orbital Atherectomy Devices
• Photo-Ablative Atherectomy Devices
• Rotational Atherectomy Devices
• Support Devices

Global Atherectomy Devices Market, by Application

• Peripheral Vascular
• Cardiovascular
• Neurovascular

Global Atherectomy Devices Market, by End User

• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Research Laboratories & Academic Institutes

Global Atherectomy Devices Market, by Region

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • RoE
• Asia Pacific
  • Japan
  • China
  • India
  • RoAPAC
• Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

• Further breakdown of the regional atherectomy devices market into countries:
• RoW into Latin America, the Middle East, and Africa.